Free Trial

Q3 EPS Estimate for Andlauer Healthcare Group Cut by Analyst

Andlauer Healthcare Group logo with Industrials background

Andlauer Healthcare Group Inc. (TSE:AND - Free Report) - Analysts at Stifel Canada reduced their Q3 2024 earnings estimates for shares of Andlauer Healthcare Group in a note issued to investors on Tuesday, October 29th. Stifel Canada analyst J. Keywood now expects that the company will earn $0.48 per share for the quarter, down from their previous estimate of $0.49. The consensus estimate for Andlauer Healthcare Group's current full-year earnings is $1.93 per share. Stifel Canada also issued estimates for Andlauer Healthcare Group's Q4 2024 earnings at $0.51 EPS and FY2024 earnings at $1.71 EPS.

Andlauer Healthcare Group (TSE:AND - Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The company reported C$0.38 earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.42 by C($0.04). Andlauer Healthcare Group had a net margin of 9.96% and a return on equity of 14.91%. The company had revenue of C$161.45 million during the quarter, compared to the consensus estimate of C$165.00 million.

Several other research firms have also recently issued reports on AND. Scotiabank dropped their price target on Andlauer Healthcare Group to C$43.00 in a report on Thursday, October 10th. Eight Capital decreased their price objective on Andlauer Healthcare Group from C$58.00 to C$51.00 and set a "buy" rating for the company in a research report on Friday, August 2nd. Royal Bank of Canada increased their price target on shares of Andlauer Healthcare Group from C$41.00 to C$42.00 and gave the stock a "sector perform" rating in a research note on Friday, August 2nd. Finally, TD Securities boosted their target price on shares of Andlauer Healthcare Group from C$52.00 to C$53.00 and gave the stock a "buy" rating in a research report on Friday, August 2nd. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of C$48.29.

Get Our Latest Research Report on Andlauer Healthcare Group

Andlauer Healthcare Group Price Performance

Shares of AND stock traded down C$0.05 during mid-day trading on Friday, hitting C$41.02. 15,140 shares of the stock traded hands, compared to its average volume of 30,561. The company has a debt-to-equity ratio of 41.86, a quick ratio of 1.66 and a current ratio of 1.35. The firm has a market cap of C$767.07 million, a price-to-earnings ratio of 27.02 and a beta of 0.66. The company's 50-day simple moving average is C$39.30 and its 200-day simple moving average is C$39.56. Andlauer Healthcare Group has a twelve month low of C$36.43 and a twelve month high of C$44.12.

Andlauer Healthcare Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Friday, September 27th were paid a $0.11 dividend. This is a positive change from Andlauer Healthcare Group's previous quarterly dividend of $0.10. This represents a $0.44 annualized dividend and a dividend yield of 1.07%. The ex-dividend date of this dividend was Friday, September 27th. Andlauer Healthcare Group's dividend payout ratio is currently 26.32%.

Andlauer Healthcare Group Company Profile

(Get Free Report)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Featured Stories

Should you invest $1,000 in Andlauer Healthcare Group right now?

Before you consider Andlauer Healthcare Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Andlauer Healthcare Group wasn't on the list.

While Andlauer Healthcare Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Netflix’s Bold Moves: 4 Strategies for Explosive Growth

Netflix’s Bold Moves: 4 Strategies for Explosive Growth

Netflix is shaking up the streaming world again with its new ad-supported tier, leading to a surge in subscribers and revenue.

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines